- Report
- April 2023
- 74 Pages
Global
From €3500EUR$3,929USD£3,035GBP
- Report
- March 2024
- 73 Pages
Global
From €3500EUR$3,929USD£3,035GBP
- Report
- March 2024
- 104 Pages
Global
From €3500EUR$3,929USD£3,035GBP
- Report
- July 2023
- 105 Pages
Global
From €3500EUR$3,929USD£3,035GBP
- Report
- April 2023
- 71 Pages
Global
From €3500EUR$3,929USD£3,035GBP
- Report
- June 2023
- 114 Pages
Global
From €3500EUR$3,929USD£3,035GBP
- Report
- May 2022
- 76 Pages
Global
€4533EUR$4,750USD£3,798GBP
- Report
- November 2021
- 302 Pages
Global
From €3340EUR$3,500USD£2,799GBP
- Report
- March 2021
- 206 Pages
Global
From €3543EUR$3,712USD£2,968GBP
The Transdermal Patch is a medical device used to deliver drugs through the skin for systemic distribution. It is a small, adhesive patch that is applied to the skin and contains a drug reservoir. The drug is then released through the skin into the bloodstream over a period of time. The patch is designed to provide a steady, controlled release of the drug, allowing for a more consistent therapeutic effect.
Transdermal Patches are used to treat a variety of conditions, including pain, allergies, and hormone replacement therapy. They are also used to deliver nicotine for smoking cessation. The patches are convenient and easy to use, and they provide a more consistent drug delivery than oral medications.
The Transdermal Patch market is a growing segment of the medical device industry. It is expected to continue to grow as more drugs are developed for transdermal delivery.
Some companies in the Transdermal Patch market include Mylan, Novartis, and Teva Pharmaceuticals. Show Less Read more